Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03162562
Title The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors OncoQuest Inc.
Indications

fallopian tube adenocarcinoma

peritoneal carcinoma

ovary epithelial cancer

Therapies

Oregovomab + Poly ICLC

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Florida Hospital Cancer Institute Orlando Florida 32804 United States Details
VCU Massey Cancer Center, Dalton Oncology Clinic Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field